Mechanistic Insights into The Role of Matrix Rhythm Therapy in Modulating Tissue Biomechanics and Axonal Demyelination in Distal Symmetric Peripheral Neuropathy: A Scoping Review
- Jun 26
- 2 min read
Research Article | 2026 | Volume 3 | Issue 3 | Page 77-87
Dr Arunima Sasidharan, Assistant Professor, Narayana Hrudayalaya Institute of Physiotherapy
Dr Shanmuga Pillai, Clinician, S.K. Physiotherapy Clinic, Bangalore
Abstract
Background: Distal Symmetric Peripheral Neuropathy (DSPN) is a progressive disease characterized by axonal degeneration, demyelination and changes in tissue mechanics leading to sensory loss, muscle weakness and chronic pain. Current treatments are focused on symptom control with minimal effect on underlying neurodegeneration. Matrix Rhythm Therapy (MRT) is a non-invasive intervention that provides rhythmic oscillations to improve cellular homeostasis, microcirculation and neuromuscular synchronization, and to reduce fibrosis. These effects may slow axonal demyelination and degeneration. This narrative review aims to discuss the impact of MRT on tissue mechanics, neural integrity and degeneration in DSPN, highlighting its therapeutic potential, mechanisms of action and clinical relevance in neurorehabilitation.Materials & Methods: A comprehensive literature analysis was conducted, involving peer-reviewed articles, clinical studies, and experimental research that addressed MRT and its effects on tissue behavior, nerve repair, and functional outcomes in neuropathic scenarios. Results: MRT has shown to improve extracellular matrix dynamics, microcirculation, reduce fibrosis and promote muscle elasticity. In addition, MRT can activate Schwann cells, facilitate myelin regeneration, and enhance nerve conduction velocity, potentially improving sensory and motor nerve function. Discussion: Matrix Rhythm Therapy demonstrated promising neuroregenerative and functional effects in DSPN, however, standardized protocols and large-scale clinical validations are required.Conclusion: Matrix Rhythm Therapy appears to be a promising adjunctive treatment of DSPN addressing tissue dysfunction, nerve degeneration and functional impairments. However, large-scale randomized controlled trials (RCTs) and mechanistic studies are needed to establish the standardized treatment protocols and long-term efficacy.
Keywords: Distal Symmetric Peripheral Neuropathy, Matrix Rhythm Therapy, Neurodegeneration, Peripheral Nerve Regeneration, Tissue Mechanics.